| Melanoma cell-intrinsic PD-1 receptor functions promote tumor growth S Kleffel, C Posch, SR Barthel, H Mueller, C Schlapbach, E Guenova, ... Cell 162 (6), 1242-1256, 2015 | 661 | 2015 |
| The cGAS–STING pathway drives type I IFN immunopathology in COVID-19 JD Domizio, MF Gulen, F Saidoune, VV Thacker, A Yatim, K Sharma, ... Nature 603 (7899), 145-151, 2022 | 311 | 2022 |
| Human TH9 cells are skin-tropic and have autocrine and paracrine proinflammatory capacity C Schlapbach, A Gehad, C Yang, R Watanabe, E Guenova, JE Teague, ... Science translational medicine 6 (219), 219ra8-219ra8, 2014 | 239 | 2014 |
| Interleukin 23 expression in pyoderma gangrenosum and targeted therapy with ustekinumab E Guenova, A Teske, B Fehrenbacher, S Hoerber, A Adamczyk, ... Archives of dermatology 147 (10), 1203-1205, 2011 | 201 | 2011 |
| ROS-induced ATF3 causes susceptibility to secondary infections during sepsis-associated immunosuppression W Hoetzenecker, B Echtenacher, E Guenova, K Hoetzenecker, ... Nature medicine 18 (1), 128-134, 2012 | 193 | 2012 |
| Nonpathogenic bacteria alleviating atopic dermatitis inflammation induce IL-10-producing dendritic cells and regulatory Tr1 cells T Volz, Y Skabytska, E Guenova, KM Chen, JS Frick, CJ Kirschning, ... Journal of Investigative Dermatology 134 (1), 96-104, 2014 | 192 | 2014 |
| TH2 Cytokines from Malignant Cells Suppress TH1 Responses and Enforce a Global TH2 Bias in Leukemic Cutaneous T-cell Lymphoma E Guenova, R Watanabe, JE Teague, JA Desimone, Y Jiang, ... Clinical Cancer Research 19 (14), 3755-3763, 2013 | 185 | 2013 |
| IL-4 abrogates TH17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cells E Guenova, Y Skabytska, W Hoetzenecker, G Weindl, K Sauer, M Tham, ... Proceedings of the National Academy of Sciences 112 (7), 2163-2168, 2015 | 184 | 2015 |
| Pyoderma gangrenosum E Maverakis, AV Marzano, ST Le, JP Callen, MC Brüggen, E Guenova, ... Nature Reviews Disease Primers 6 (1), 81, 2020 | 180 | 2020 |
| The PROCLIPI international registry of early‐stage mycosis fungoides identifies substantial diagnostic delay in most patients JJ Scarisbrick, P Quaglino, HM Prince, E Papadavid, E Hodak, M Bagot, ... British Journal of Dermatology 181 (2), 350-357, 2019 | 174 | 2019 |
| Adverse cutaneous drug eruptions: current understanding W Hoetzenecker, M Nägeli, ET Mehra, AN Jensen, I Saulite, ... Seminars in immunopathology 38, 75-86, 2016 | 173 | 2016 |
| Cutaneous innate immune sensing of Toll-like receptor 2-6 ligands suppresses T cell immunity by inducing myeloid-derived suppressor cells Y Skabytska, F Wölbing, C Günther, M Köberle, S Kaesler, KM Chen, ... Immunity 41 (5), 762-775, 2014 | 143 | 2014 |
| Toll-like receptor 2 ligands promote chronic atopic dermatitis through IL-4–mediated suppression of IL-10 S Kaesler, T Volz, Y Skabytska, M Köberle, U Hein, KM Chen, E Guenova, ... Journal of Allergy and Clinical Immunology 134 (1), 92-99. e6, 2014 | 142 | 2014 |
| Natural Staphylococcus aureus‐derived peptidoglycan fragments activate NOD2 and act as potent costimulators of the innate immune system exclusively in the … T Volz, M Nega, J Buschmann, S Kaesler, E Guenova, A Peschel, ... The FASEB Journal 24 (10), 4089-4102, 2010 | 136 | 2010 |
| Basal serum tryptase as risk assessment for severe Hymenoptera sting reactions in elderly E Guenova, T Volz, M Eichner, W Hoetzenecker, U Caroli, G Griesinger, ... Allergy 65 (7), 919-923, 2010 | 97 | 2010 |
| Dualism of FGF and TGF-β signaling in heterogeneous cancer-associated fibroblast activation with ETV1 as a critical determinant P Bordignon, G Bottoni, X Xu, AS Popescu, Z Truan, E Guenova, L Kofler, ... Cell reports 28 (9), 2358-2372. e6, 2019 | 85 | 2019 |
| Characteristics associated with significantly worse quality of life in mycosis fungoides/Sezary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index … K Molloy, C Jonak, F Woei‐A‐Jin, E Guenova, AM Busschots, A Bervoets, ... British Journal of Dermatology 182 (3), 770-779, 2020 | 83 | 2020 |
| Oncolytic virotherapy-mediated anti-tumor response: a single-cell perspective E Ramelyte, A Tastanova, Z Balázs, D Ignatova, P Turko, U Menzel, ... Cancer cell 39 (3), 394-406. e4, 2021 | 74 | 2021 |
| Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC EA Olsen, S Whittaker, R Willemze, L Pinter-Brown, F Foss, L Geskin, ... Blood, The Journal of the American Society of Hematology 140 (5), 419-437, 2022 | 70 | 2022 |
| European dermatology forum–updated guidelines on the use of extracorporeal photopheresis 2020–part 1 R Knobler, P Arenberger, A Arun, C Assaf, M Bagot, G Berlin, A Bohbot, ... Journal of the European Academy of Dermatology and Venereology 34 (12), 2693 …, 2020 | 65 | 2020 |
Wolfram HoetzeneckerKantonsspital St. Gallen, SchweizVerified email at usz.ch
